Collecting data and offering big data analytics to speed up research for personalized treatment for blood cancer patients.
Big Data has proven to offer new insights that can contribute to advances in novel therapies and more efficient medicines. We invite researchers across the globe to embrace cooperation to foster blood cancer research.
News
December 20, 2024
November 27, 2024
October 14, 2024
We created the innovative HARMONY Alliance Big Data Platform,
a central analytical infrastructure, to harmonize data sets donated by
European hospitals, academic institutions conducting clinical trials,
and pharmaceutical companies, among other data custodians.
Our data lake is one of the largest databases of its kind, and still growing.
Careful procedures ensure the anonymization and the quality of the data.
We offer sophisticated methods for data harmonization and analysis.
Meet us
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
